Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASAD for Diarrhea in Medullary Thyroid Cancer
NCT01739634Phase 2Unknown
- Sponsor
- Salient Pharmaceuticals
- Start
- Nov 2012
- Primary completion
- Dec 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of calcium aluminosilicate in diarrhea, sponsored by Salient Pharmaceuticals. Status: unknown.
02
Drugs
calcium aluminosilicate
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT01739634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01739634.